Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Operating Activities:
Net (loss) income	$ (122)	$ 23,116
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization	27,024	28,083
Amortization (accretion) of debt discount (premium) and consumer loan premium (discount), net	6,512	(68)
Consumer loan loss provision	23,465	28,901
Deferred income taxes	(5,742)	(1,280)
Impairment of goodwill	10,550	0
Restructuring	763	0
Amortization of deferred financing costs	3,423	4,166
Amortization of prepaid commissions	9,878	10,039
Other adjustments	1,215	(753)
Loss (gain) on sale or disposal of assets	956	(6,137)
Stock compensation (benefit) expense	(1,319)	9,487
Income from investments in unconsolidated affiliates	(338)	(3,880)
Impairment of investments	0	7,940
Changes in operating assets and liabilities, net of business acquisitions:
Service charges and fees receivable	(5,360)	1,577
Inventory	926	2,243
Receivables, prepaid expenses, other current assets and other assets	(39,237)	(35,349)
Accounts payable and other accrued expenses and deferred gains and other long-term liabilities	3,942	(9,476)
Customer layaway deposits	1,127	(433)
Restricted cash	(214)	0
Prepaid income taxes	11,885	(20,048)
Payments of restructuring charges	(3,668)	0
Dividends from unconsolidated affiliates	4,842	5,129
Net cash provided by operating activities	50,508	43,257
Investing activities:
Loans made	(640,278)	(705,181)
Loans repaid	474,074	498,222
Recovery of pawn loan principal through sale of forfeited collateral	191,170	182,004
Additions to property and equipment	(22,849)	(15,930)
Acquisitions, net of cash acquired	(4,120)	(12,990)
Investments in unconsolidated affiliates	(12,140)	0
Proceeds from sale of assets	0	10,631
Other investing activities	0	143
Net cash used in investing activities	(14,143)	(43,101)
Financing activities:
Taxes paid related to net share settlement of equity awards	(196)	(1,990)
Debt issuance costs	0	(12,686)
Payout of deferred and contingent consideration	(6,000)	(23,000)
Proceeds from issuance of convertible notes	0	200,000
Purchase of convertible notes hedges	0	(40,395)
Proceeds from issuance of warrants	0	21,824
Purchase of subsidiary shares from noncontrolling interest	(2,774)	(21,139)
Proceeds from settlement of forward currency contracts	2,313	0
Change in restricted cash	30,335	(40,761)
Proceeds from revolving line of credit	0	389,900
Payments on revolving line of credit	0	(530,800)
Proceeds from borrowings	69,296	154,406
Payments on borrowings and capital lease obligations	(64,586)	(63,162)
Repurchase of common stock	0	(11,901)
Net cash provided by financing activities	28,388	20,296
Effect of exchange rate changes on cash and cash equivalents	(5,691)	(118)
Net increase in cash and cash equivalents	59,062	20,334
Cash and cash equivalents at beginning of period	55,325	29,100
Cash and cash equivalents at end of period	114,387	49,434
Non-cash investing and financing activities:
Pawn loans forfeited and transferred to inventory	170,185	171,288
Issuance of common stock, subject to possible redemption, due to acquisition	11,696	0
Deferred consideration	124	2,692
Issuance of common stock to 401(k) plan	0	557
Equity adjustment due to noncontrolling interest purchase	0	6,588
Receivable from issuance of convertible notes	0	30,000
Payable to purchase convertible notes hedges	0	6,059
Warrants receivable related to issuance of convertible notes	0	3,282
Deferred finance cost payable related to convertible notes	0	2,400
Payable to purchase additional shares of noncontrolling interest	$ 322	$ 8,636